Retrospective analysis of the effectiveness of a reduced dose of idarucizumab in dabigatran reversal.
Louisa StoneEileen MerrimanGordon RoyleMerit HannaHenry S H ChanPublished in: Thrombosis and haemostasis (2021)
An initial 2.5g dose of idarucizumab appears effective for dabigatran reversal in the real-world setting.